AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 268: R1117-R1120, 1995;
0363-6119/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gough, S. R.
Right arrow Articles by Conrad, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gough, S. R.
Right arrow Articles by Conrad, K. P.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 5 1117-R1120, Copyright © 1995 by American Physiological Society


ARTICLES

Metabolism of erythropoietin in conscious pregnant rats

S. R. Gough, M. D. Mosher and K. P. Conrad
Department of Physiology and Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque 87131, USA.

Circulating erythropoietin (EPO) concentration increases during human and rat gestation, thereby contributing to the expansion of red cell mass. However, the mechanism(s) underlying gestational increases of the hormone is unknown. Our objective was to define whether the elevated EPO levels are secondary to decreased metabolic clearance or to enhanced production. The half-life of the hormone was also measured. A bolus and a constant infusion of 125I-labeled recombinant human EPO (125I-rhEPO) were administered to chronically instrumented conscious pregnant and virgin rats. The metabolic clearance rate of the 125I-rhEPO was slightly but significantly higher in gravid rats than in the virgin control animals (0.13 +/- 0.01 vs. 0.10 +/- 0.01 ml/min). The plasma half-life of 125I-rhEPO was 2.9 +/- 0.1 h for the pregnant rats and 2.9 +/- 0.2 h for the virgin controls. To confirm these results obtained by using 125I-rhEPO, EPO-rich plasma was generated in anemic rats and administered to another group of conscious virgin and pregnant rats. The half-life of homologous EPO was 2.9 +/- 0.5 and 3.3 +/- 0.1 h for gravid and virgin rats, respectively (P = NS). We conclude that elevated circulating EPO in rat gestation is secondary to increased biosynthesis and not to decreased metabolic clearance.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Moritz, G. B. Lim, and E. M. Wintour
Developmental regulation of erythropoietin and erythropoiesis
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1829 - R1844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online